There is 1 paper on renal morbidity in aging research: 1 observational study in people.
1 paper studies it13 more mention it1 finding
4 new papers in 30 daysSee all 14 papers on renal morbidity
“the greatest contributor to outcomes for Black respondents was renal morbidity”
- Humans1
Associations
1Mortality
upin humans1
1 study
Mortality
upin humans1
Renal morbidity is linked with a higher risk of mortality in humans among Black respondents.
“the greatest contributor to outcomes for Black respondents was renal morbidity”
Humansamong Black respondents
American journal of epidemiology
Latest
8 papers in 12 monthsScientific Reports
Metabolite and protein associations with general health in the population-based CHRIS study
Cross-sectional study of 3,142 peopleBiomarkers
Journal of the Saudi Heart Association
Saudi Heart Association Position Statement on the Management of Uncontrolled and Resistant Hypertension
ReviewIndustry & policy
AHA Scientific Sessions 2026 Abstract
Temporal Trends in Utilization of Cardiovascular-Kidney-Metabolic Syndrome Directed Therapies Among Patients with HFpEF: A Contemporary Real-World Analysis of Over 1.2 Million Patients
Cohort study in peopleCardiovascular-kidney-metabolic syndrome
AHA Scientific Sessions 2026 Abstract
Rising National Mortality Trends Involving Hypertensive Heart and Renal Disease and Diabetes Mellitus in the United States, 1999-2024
Cross-sectional study of 65,934 peopleDiabetes mellitus
Saudi Journal of Kidney Diseases and Transplantation
Red cell distribution width predicts chronic kidney disease in elderly uncontrolled type 2 diabetic patients
Cohort study of 650 peopleRed cell distribution width
The Israel Medical Association Journal
Clinical Outcomes of Renal Denervation for Resistant Hypertension: The Tel Aviv Renal Denervation Prospective Registry
Cohort study of 19 peopleRenal denervation
Journal of Pharmacy & Bioallied Sciences
Comparative Study on the Efficacy of Different Antihypertensive Classes in Early-Stage Hypertension with Renal Function Consideration
Randomized trial in 120 peopleKidney disease
Nature Reviews Drug Discovery
GLP-1-based therapies for diabetes, obesity and beyond
ReviewType 2 diabetes